Edvonova is advancing women’s health research by transforming biologically relevant specimens into innovative research solutions. At the heart of our vision is menstrual blood—a non-invasive, readily accessible, and information-rich biospecimen containing cellular, molecular, and immunological information that may provide new opportunities for understanding, predicting, and monitoring women’s diseases.

Our research approach explores menstrual blood as a potential window into women’s health, with applications extending from reproductive and inflammatory conditions to the investigation of diseases such as endometriosis and dysmenorrhea. By characterizing cellular and molecular signatures in menstrual blood, Edvonova aims to contribute to the discovery of predictive biomarkers and new approaches for disease research, drug development, and personalized women’s health.

Healthy aging in women is another strategic focus of Edvonova. We investigate age-related changes in immunity, inflammation, cellular function, and disease susceptibility, with the aim of advancing research into healthy immune longevity and supporting a better understanding of how women can maintain health throughout the aging process.

To support women’s oncology research, Edvonova provides curated immunohistochemistry (IHC) antibody panels for breast, ovarian, fallopian tube, endometrial, and cervical cancers. These research tools enable robust tissue-based analyses and support molecular characterization, biomarker research, and translational studies.

Edvonova also develops and supplies laboratory instrumentation designed to enhance analytical precision, workflow standardization, and reproducibility. Complementing our scientific portfolio, we offer the Serenova menstrual cup and sterilizer set, connecting scientific innovation with practical, safe, hygienic, and sustainable menstrual health management.

Through the integration of biospecimen research, biomarker discovery, immune and healthy aging research, oncology, and practical women’s health solutions, Edvonova is working toward a future in which accessible biological information can contribute to earlier insights, better prediction, and more personalized approaches to women’s health.